Home
About Us
Company Profile
Qualification
Technology
Corporate Image
Organization Chart
Culture
Products
Health Care
Antiviral
Anti-Platelet Coagulation
Anti-Inflammatory
Anti-Tumor
Veterinary Drugs
Anti-Diabetic
Cephalosporins
Anti-Cardiovascular And Cerebrovascular Diseases
Others
News
Company News
Industry News
Contact Us
Join Us
NEWS
The Chinese patent office has rejected a patent application for the blockbuster hepatitis C treatment sofosbuvir, increasing the possibility of a generic version of the drug to become available in Chi